Rick E. Winningham - 20 Feb 2023 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
20 Feb 2023
Net transactions value
-$390,665
Form type
4
Filing time
22 Feb 2023, 18:29:45 UTC
Previous filing
16 Dec 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability $390,665 -37,420 -2.8% $10.44 1,313,377 20 Feb 2023 Direct F1
holding TBPH Ordinary Shares 92,567 20 Feb 2023 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.